Cormorant Asset Management, LP, Director at Erasca, Inc. (ERAS), bought 307,692 shares at $6.50 ($2.0M) on 2022-12-13, disclosed to the SEC on 2022-12-21.
Open-market purchase of $2.0M ERAS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| DRUG | BUY | 2024-11-06 | $8.0M | — | Filing → |
| EYPT | BUY | 2024-05-08 | $20.2M | — | Filing → |
| CRBP | BUY | 2024-02-06 | $14.3M | — | Filing → |